Dedík L, Durisová M
Faculty of Mechanical Engineering, Slovak Technical University, Bratislava.
J Pharmacokinet Biopharm. 1994 Aug;22(4):293-307. doi: 10.1007/BF02353623.
The paper presents the demonstration of applicability of the frequency response method in a bioavailability study. The frequency response method, common in system engineering, is based on an approximation of the frequency response of a linear dynamic system, calculated from input-output measurements, by a frequency model of the system transfer function in the frequency domain. In general, the influence of the system structure on the form of the system frequency response is much more distinct than on the form of the system output. This is of great advantage in modeling the system frequency response instead of the system output, commonly used in pharmacokinetics. After a brief theoretical section, the method is demonstrated on the estimation of the rate and extent of gentamicin bioavailability after intratracheal administration to guinea pigs. The optimal frequency model of the system describing the gentamicin pathway into the systemic circulation and point estimates of its parameters were selected by the approximation of the system frequency response in the frequency domain, using a noniterative algorithm. Two similar estimates of the system weighing function were independently obtained: the weighting function of the selected frequency model and the weighting function estimated by the numerical deconvolution procedure. Neither of the estimates of the weighting function does decrease monotonously after the maximum of about 2.2-2.5 unit of dose hr-1 recorded approximately 0.1 hr after drug administration. Both estimates show a marked additional peak approximately at 0.3 hr after administration and possible peaks in the further time period. We hypothesized that the loop found in the frequency response calculated and in the selected optimal frequency model, the high-order of this model, and several peaks identified in the estimates of the system weighting function indicated the complexity of the system and the presence of time delays. Three estimates of the extent of gentamicin intratracheal bioavailability obtained by the three different ways: directly from the calculated frequency response, calculated using the selected frequency model, and by the deconvolution method were 0.950, 0.934, and 0.907 respectively. Thus the conclusion can be made that gentamicin injected intratracheally to guinea pigs is almost completely available.
本文展示了频率响应法在生物利用度研究中的适用性。频率响应法在系统工程中较为常见,它基于对线性动态系统频率响应的近似,该近似通过在频域中根据输入 - 输出测量值计算得到的系统传递函数的频率模型来实现。一般来说,系统结构对系统频率响应形式的影响比对系统输出形式的影响更为明显。这在对系统频率响应而非药代动力学中常用的系统输出进行建模时具有很大优势。在简短的理论部分之后,该方法通过对豚鼠气管内给药后庆大霉素生物利用度的速率和程度的估计进行了演示。通过使用非迭代算法在频域中对系统频率响应进行近似,选择了描述庆大霉素进入体循环途径的系统的最佳频率模型及其参数的点估计值。独立获得了系统加权函数的两个相似估计值:所选频率模型的加权函数和通过数值去卷积程序估计的加权函数。在给药后约0.1小时记录到剂量约为2.2 - 2.5单位·小时⁻¹的最大值后,加权函数的两个估计值均不会单调下降。两个估计值在给药后约0.3小时均显示出明显的额外峰值,并在后续时间段可能存在峰值。我们假设在计算得到的频率响应和所选最佳频率模型中发现的环路、该模型的高阶以及在系统加权函数估计值中识别出的几个峰值表明了系统的复杂性和时间延迟的存在。通过三种不同方式获得的庆大霉素气管内生物利用度程度的三个估计值:直接从计算得到的频率响应、使用所选频率模型计算以及通过去卷积方法,分别为0.950、0.934和0.907。因此,可以得出结论,向豚鼠气管内注射的庆大霉素几乎完全可用。